Opioids Often Given in Excess to Patients

Opioids Often Given in Excess to Patients

A majority of people prescribed opioid medications for pain said that they were given more than they needed, according to a recent survey, making it easier for some people to abuse the drugs or share them with others.

Just as disturbing, more than 20% of the 1,055 patients surveyed by researchers at the Johns Hopkins Bloomberg School of Public Health in Baltimore said they shared their pain meds with others.

Researchers asked more than 1,000 people who were prescribed opioids in the past year about the use of the drugs, how they stored them and whether they shared them with others. Almost 60% said they had leftover medications from their prescription or expected to, the authors reported in JAMA Internal Medicine.

Among people who shared their meds, about 8% gave them to a friend and 14% gave them to a relative. And about 75% gave their extra pills to someone they knew suffering from pain.

Another problem identified in the survey was proper storage of the medication. Among those who said they received information about storage, just one-third said it came from a doctor or nurse. A pharmacist or drug package inset was the source about 45% of the time.

Less than 10% kept their opioids locked away, and about 20% said they stored them in a “latched” location. In addition, relatively few survey participants knew how to properly dispose of their unused pills.

A separate study in the same issue of JAMA Internal Medicine found that in many cases, long-term use of opioids starts with short-term hospitalization.

This study, which included more than 600,000 Medicare recipients, found that 15% of hospital patients get a new opioid prescription when they leave the hospital. And of these patients, nearly 43% were still taking opioids more than 3 months later.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement